Atlas Trials

An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)

Clinical trial NCT02856230 · UNKNOWN

Trial details

NCT number
NCT02856230
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lower Limb IschemiaPeripheral Vascular Diseases
Start date
2016-11-01
Primary completion
2018-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.